EPS (Diluted) for Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current diluted EPS (TTM) is $14.23. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$14.23
YoY change
+88.2%
5Y CAGR
+2.9%
Peak year (2025)
$14.23
Latest annual
$14.23
EPS (Diluted) history chart for Amgen (AMGN) from 1985 to 2025
EPS (Diluted) history table for Amgen (AMGN) from 1985 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $14.23 | +88.2% | ||
| 2024 | $7.56 | -39.5% | ||
| 2023 | $12.49 | +3.1% | ||
| 2022 | $12.11 | +17.8% | ||
| 2021 | $10.28 | -16.5% | ||
| 2020 | $12.31 | -4.4% | ||
| 2019 | $12.88 | +2.1% | ||
| 2018 | $12.62 | +369.1% | ||
| 2017 | $2.69 | -73.7% | ||
| 2016 | $10.24 | +13.0% | ||
| 2015 | $9.06 | +35.2% | ||
| 2014 | $6.70 | +0.9% | ||
| 2013 | $6.64 | +20.3% | ||
| 2012 | $5.52 | +36.6% | ||
| 2011 | $4.04 | -15.7% | ||
| 2010 | $4.79 | +6.2% | ||
| 2009 | $4.51 | +19.6% | ||
| 2008 | $3.77 | +33.7% | ||
| 2007 | $2.82 | +13.7% | ||
| 2006 | $2.48 | -15.4% | ||
| 2005 | $2.93 | +61.9% | ||
| 2004 | $1.81 | +7.1% | ||
| 2003 | $1.69 | -239.7% | ||
| 2002 | $-1.21 | -217.5% | ||
| 2001 | $1.03 | -1.9% | ||
| 2000 | $1.05 | +2.9% | ||
| 1999 | $1.02 | +24.4% | ||
| 1998 | $0.82 | +39.0% | ||
| 1997 | $0.59 | -3.3% | ||
| 1996 | $0.61 | +29.8% | ||
| 1995 | $0.47 | +67.9% | ||
| 1994 | $0.28 | -20.0% | ||
| 1993 | $0.35 | +12.9% | ||
| 1992 | $0.31 | +244.4% | ||
| 1991 | $0.09 | +200.0% | ||
| 1990 | $0.03 | — | ||
| 1988 | $-0.01 | -655.6% | ||
| 1987 | $0.00 | +100.0% | ||
| 1986 | $0.00 | 0.0% | ||
| 1985 | $0.00 | — |
EPS (Diluted) values are taken from Amgen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Amgen (AMGN) diluted EPS totalled $14.23 – surged 88.2% year-over-year.
Across 2020–2025 (5 years), Amgen diluted EPS produced a CAGR of +2.9% – with the latest reading among the more recent periods of the dataset.
The highest annual diluted EPS of $14.23 was reported in 2025. The lowest in the available history was $-1.21 in 2002.
Among 8 Healthcare peers, Amgen (AMGN) ranks 4th; the peer median for diluted EPS is $13.16.
Amgen EPS (Diluted) by Year
Amgen EPS (Diluted) 2025: $14.23
Amgen diluted EPS in 2025 was $14.23, surged 88.2% from 2024. This figure represents the highest annual value in the available history.
Amgen EPS (Diluted) 2024: $7.56
Amgen diluted EPS in 2024 was $7.56, plunged 39.5% below 2023.
Amgen EPS (Diluted) 2023: $12.49
Amgen diluted EPS in 2023 was $12.49, edged up 3.1% from 2022.
Amgen EPS (Diluted) 2022: $12.11
Amgen diluted EPS in 2022 was $12.11, grew 17.8% from 2021.
Amgen EPS (Diluted) 2021: $10.28
Amgen diluted EPS in 2021 was $10.28.
See more financial history for Amgen (AMGN).
Sector peers — EPS (Diluted)
Companies in the same sector as Amgen, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $17.74 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Amgen's diluted EPS?
- Latest reported diluted EPS for Amgen (AMGN) is $14.23 (period ending December 31, 2025).
How has Amgen diluted EPS changed year-over-year?
- Amgen (AMGN) diluted EPS changed +88.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen diluted EPS?
- Amgen (AMGN) diluted EPS compound annual growth rate is +2.9% over the most recent 5 years available.
When did Amgen diluted EPS hit its highest annual value?
- Amgen diluted EPS reached its highest annual value of $14.23 in 2025.
What was Amgen diluted EPS in 2024?
- Amgen (AMGN) diluted EPS in 2024 was $7.56.
What was Amgen diluted EPS in 2025?
- Amgen (AMGN) diluted EPS in 2025 was $14.23.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.